Real-world effectiveness of piperacillin/tazobactam with and without linezolid for spontaneous bacterial peritonitis

S Quickert, S Würstle, PA Reuken, S Hagel… - Digestive …, 2022 - karger.com
Background: Guidelines recommend empirical therapy with piperacillin/tazobactam (TZP) for
spontaneous bacterial peritonitis (SBP) with low risk of multidrug-resistant organisms …
被引用次数：5 相关文章

Real-World Effectiveness of Piperacillin/Tazobactam with and without Linezolid for Spontaneous Bacterial Peritonitis

S Quickert, S Würstle, PA Reuken, S Hagel… - Digestive …, 2022 - karger.com
Background: Guidelines recommend empirical therapy with piperacillin/tazobactam (TZP) for
spontaneous bacterial peritonitis (SBP) with low risk of multidrug-resistant organisms …

Real-World Effectiveness of Piperacillin/Tazobactam with and without Linezolid for Spontaneous Bacterial Peritonitis.

S Quickert, S Würstle, PA Reuken, S Hagel… - Digestive Diseases …, 2022 - europepmc.org
Background Guidelines recommend empirical therapy with piperacillin/tazobactam (TZP) for
spontaneous bacterial peritonitis (SBP) with low risk of multidrug-resistant organisms …

Real-World Effectiveness of Piperacillin/Tazobactam with and without Linezolid for Spontaneous Bacterial Peritonitis.

S Quickert, S Würstle, PA Reuken, S Hagel… - Digestive …, 2022 - search.ebscohost.com
Background: Guidelines recommend empirical therapy with piperacillin/tazobactam (TZP) for
spontaneous bacterial peritonitis (SBP) with low risk of multidrug-resistant organisms …

Real-World Effectiveness of Piperacillin/Tazobactam with and without Linezolid for Spontaneous Bacterial Peritonitis.

S Quickert, S Würstle, PA Reuken, S Hagel… - 2022 - mediatum.ub.tum.de
BACKGROUND: Guidelines recommend empirical therapy with piperacillin/tazobactam
(TZP) for spontaneous bacterial peritonitis (SBP) with low risk of multidrug-resistant …

Real-World Effectiveness of Piperacillin/Tazobactam with and without Linezolid for Spontaneous Bacterial Peritonitis

S Quickert, S Würstle, PA Reuken… - Digestive diseases …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Guidelines recommend empirical therapy with piperacillin/tazobactam (TZP) for
spontaneous bacterial peritonitis (SBP) with low risk of multidrug-resistant organisms …